Verhaagen Groep: Neurodegeneratieve ziektes, dwarslaesie, neuroregeneratie, gentherapie
Vision on gyrate atrophymRNA trans-splicing dual AAV vectors for (epi)genome editing and gene therapyImproving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cellsThe concept of resilience to Alzheimer's DiseaseCharacterization and AAV-mediated CRB gene augmentation in human-derived CRB1KO and CRB1KOCRB2+/- retinal organoidsGene-expression profiling of individuals resilient to Alzheimer's disease reveals higher expression of genes related to metallothionein and mitochondrial processes and no changes in the unfolded protein responseStabilization of V1 interneuron-motor neuron connectivity ameliorates motor phenotype in a mouse model of ALSParkinson's Disease
organisationalUnits
Verhaagen Groep: Neurodegeneratieve ziektes, dwarslaesie, neuroregeneratie, gentherapie
type
label
Verhaagen Groep: Neurodegeneratieve ziektes, dwarslaesie, neuroregeneratie, gentherapie
@en
oracle_ebs_id
name
Verhaagen Groep: Neurodegeneratieve ziektes, dwarslaesie, neuroregeneratie, gentherapie
@en
visibility
Public - No restriction
@en
Publiek - Geen beperking
@nl